CLINICAL_TRIALS trial_result · 2020-02-28

Clinical Trial Update: STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]

Phase 2 clinical trial of STX-100 in idiopathic pulmonary fibrosis (IPF) has completed and results were posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Biogen | Conditions: Idiopathic Pulmonary Fibrosis (IPF) | Phase 2 | Status: COMPLETED | Results posted: 2020-02-28